Availability of Cisplatin

HPS Pharmacies wish to advise that Accord Healthcare is experiencing a supply interruption for cisplatin as follows:

Cisplatin Accord
Cisplatin 50 mg/50 mL
ARTG 286786

 Cisplatin Accord
Cisplatin 100 mg/100 mL
ARTG 286791

Normal supplies of the 50mg presentation are expected to resume by end-July 2024; supplies of the 100mg presentation are expected by end-June 2024. Supplies of DBL Cisplatin 100mg/100mL are expected to be available from early June 2024. Limited supplies of DBL Cisplatin 50mg/50mL are currently available in some warehouses.

Two internationally registered brands of cisplatin have been approved for supply via Section 19A of the Therapeutic Goods Act 1989. Both products contain cisplatin 100mg/100mL. The Fresenius Kabi (USA) product is presented as multiple dose vials and the Accord (UK) product is presented as single-use vials.

Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact Accord on 1800 222 673, or your pharmacist at HPS Pharmacies.

Download PDF